INVO Fertility divests majority holdings in NTI, retains preferred stake and note

INVO Fertility, Inc.

Effective June 2, 2025, INVO redeemed all Series C-1 Preferred for 3,227,813 shares of NTI Class A Common, ceasing to hold NTI common.
INVO retains 6,300 shares of NTI Series A Preferred, representing 19.9% on an as-converted basis, and a $4.8M secured convertible note from NTI.
Pro forma net loss improves: Q1 2025 from $17.4M to $16.2M; FY 2024 from $9.1M to $5.7M after removing NTI operations.
The divestiture removes NTI's intangible assets ($14.8M) and goodwill ($3.0M) from INVO's balance sheet.

item 2.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.